Azzad Asset Management Inc /Adv Regeneron Pharmaceuticals, Inc. Transaction History

Azzad Asset Management Inc /Adv

$891 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Apr 01, 2024	SELL	$705.89 - $766.39 $2.18 Million - $2.37 Million	-3,093 Closed	0 $0
Q3 2022 Apr 01, 2024	SELL	$573.97 - $724.32 $1.15 Million - $1.45 Million	-2,000 Reduced 39.27%	3,093 $1.97 Billion
Q2 2022 Apr 01, 2024	BUY	$548.35 - $738.84 $1.4 Million - $1.89 Million	2,555 Added 100.67%	5,093 $3.09 Billion
Q1 2022 Apr 01, 2024	SELL	$595.12 - $698.43 $469,549 - $551,061	-789 Reduced 23.72%	2,538 $1.77 Billion
Q4 2021 Apr 01, 2024	BUY	$543.48 - $670.97 $17,391 - $21,471	32 Added 0.97%	3,327 $2.1 Billion
Q3 2021 Apr 01, 2024	BUY	$574.03 - $680.96 $42,478 - $50,391	74 Added 2.3%	3,295 $1.99 Billion
Q2 2021 Apr 01, 2024	SELL	$472.8 - $558.54 $47,280 - $55,854	-100 Reduced 3.01%	3,221 $1.8 Billion
Q1 2021 Apr 01, 2024	BUY	$446.73 - $548.2 $104,088 - $127,730	233 Added 7.55%	3,321 $1.57 Billion
Q4 2020 Apr 01, 2024	SELL	$478.3 - $607.98 $1,434 - $1,823	-3 Reduced 0.1%	3,088 $1.49 Billion
Q3 2020 Apr 01, 2024	BUY	$544.75 - $658.21 $308,873 - $373,205	567 Added 22.46%	3,091 $1.73 Billion
Q2 2020 Apr 01, 2024	SELL	$493.32 - $643.92 $287,605 - $375,405	-583 Reduced 18.76%	2,524 $1.57 Billion
Q1 2020 Apr 01, 2024	SELL	$336.18 - $494.43 $819,270 - $1.2 Million	-2,437 Reduced 43.96%	3,107 $1.52 Billion
Q4 2019 Apr 01, 2024	BUY	$274.13 - $376.51 $15,351 - $21,084	56 Added 1.02%	5,544 $2.71 Billion
Q3 2019 Apr 01, 2024	BUY	$273.46 - $318.39 $1.5 Million - $1.75 Million	5,488 New	5,488 $2.4 Billion
Q2 2017 Apr 03, 2024	SELL	N/A	-652 Closed	0 $0
Q1 2016 Apr 03, 2024	SELL	N/A	-1 Reduced 0.15%	652 $235 Million
Q4 2015 Apr 03, 2024	SELL	N/A	-2 Reduced 0.31%	653 $354 Million
Q2 2015 Apr 03, 2024	SELL	N/A	-855 Reduced 56.62%	655 $334 Million
Q4 2014 Apr 03, 2024	SELL	N/A	-953 Reduced 38.69%	1,510 $620 Million
Q2 2014 Apr 03, 2024	SELL	N/A	-525 Reduced 17.57%	2,463 $696 Million
Q1 2014 Apr 03, 2024	BUY	N/A	37 Added 1.25%	2,988 $897 Million
Q4 2013 Apr 03, 2024	BUY	N/A	43 Added 1.48%	2,951 $812 Million
Q2 2013 Apr 03, 2024	BUY	N/A	460 Added 18.79%	2,908 $694 Million
Q1 2013 Apr 03, 2024	BUY	N/A	2,448 New	2,448 $432 Million
Q4 2012 Apr 08, 2024	BUY	N/A	2,476	2,476 $424 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Account